Literature DB >> 15713776

Molecular imaging in the clinical arena.

Farouc A Jaffer1, Ralph Weissleder.   

Abstract

Molecular imaging is an emerging field that aims to integrate patient-specific and disease-specific molecular information with traditional anatomical imaging readouts. The information provided by this field may ultimately allow for noninvasive or minimally invasive molecular diagnostic capabilities, better clinical risk stratification, more optimal selection of disease therapy, and improved assessment of treatment efficacy. In this update, we first provide an overview of clinically relevant molecular imaging technologies and imaging agents. Next, their applications to disease detection, drug discovery, and biomedical research are discussed. To specifically demonstrate the potential of molecular imaging, we highlight recent advances in clinical and preclinical molecular imaging of cancer and atherosclerosis.

Entities:  

Mesh:

Year:  2005        PMID: 15713776     DOI: 10.1001/jama.293.7.855

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  97 in total

1.  Advancing molecular imaging: a chairman's perspective on how radiology can meet the challenge.

Authors:  Hedvig Hricak
Journal:  Pediatr Radiol       Date:  2010-08-31

2.  Optical Imaging of Bacterial Infection Models.

Authors:  W Matthew Leevy; Nathan Serazin; Bradley D Smith
Journal:  Drug Discov Today Dis Models       Date:  2007

3.  Albumin-based nanoparticles as magnetic resonance contrast agents: II. Physicochemical characterisation of purified and standardised nanoparticles.

Authors:  A A Abdelmoez; G C Thurner; E A Wallnöfer; N Klammsteiner; C Kremser; H Talasz; M Mrakovcic; E Fröhlich; W Jaschke; P Debbage
Journal:  Histochem Cell Biol       Date:  2010-07-14       Impact factor: 4.304

4.  Human ferritin cages for imaging vascular macrophages.

Authors:  Masahiro Terashima; Masaki Uchida; Hisanori Kosuge; Philip S Tsao; Mark J Young; Steven M Conolly; Trevor Douglas; Michael V McConnell
Journal:  Biomaterials       Date:  2010-11-11       Impact factor: 12.479

Review 5.  Biological imaging for selecting and monitoring cancer therapy; a pathway to individualised therapy.

Authors:  Markus Schwaiger; Christian Peschel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-07       Impact factor: 9.236

6.  Selective imaging of adherent targeted ultrasound contrast agents.

Authors:  S Zhao; D E Kruse; K W Ferrara; P A Dayton
Journal:  Phys Med Biol       Date:  2007-03-20       Impact factor: 3.609

7.  Molecular imaging of glucose uptake in oral neoplasia following topical application of fluorescently labeled deoxy-glucose.

Authors:  Nitin Nitin; Alicia L Carlson; Tim Muldoon; Adel K El-Naggar; Ann Gillenwater; Rebecca Richards-Kortum
Journal:  Int J Cancer       Date:  2009-06-01       Impact factor: 7.396

8.  Confocal microscopy and molecular-specific optical contrast agents for the detection of oral neoplasia.

Authors:  Alicia L Carlson; Ann M Gillenwater; Michelle D Williams; Adel K El-Naggar; R R Richards-Kortum
Journal:  Technol Cancer Res Treat       Date:  2007-10

Review 9.  Methods and challenges in quantitative imaging biomarker development.

Authors:  Richard G Abramson; Kirsteen R Burton; John-Paul J Yu; Ernest M Scalzetti; Thomas E Yankeelov; Andrew B Rosenkrantz; Mishal Mendiratta-Lala; Brian J Bartholmai; Dhakshinamoorthy Ganeshan; Leon Lenchik; Rathan M Subramaniam
Journal:  Acad Radiol       Date:  2015-01       Impact factor: 3.173

Review 10.  In silico cancer modeling: is it ready for prime time?

Authors:  Thomas S Deisboeck; Le Zhang; Jeongah Yoon; Jose Costa
Journal:  Nat Clin Pract Oncol       Date:  2008-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.